Our response to the letter to the editor

Affiliations

¹ Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan; Cell and Tissue Culture Laboratory, Centre for Advanced Research in Sciences (CARS), University of Dhaka, Dhaka, Bangladesh.
² Save the Children, Bangladesh.
³ Kobayashi Pediatric Clinic, Shizuoka, Japan.
⁴ Department of Developmental Medical Sciences, School of International Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
⁵ Infectious Diseases Department, International University of Health & Welfare (IUHW), Chiba, Japan.
⁶ Public Health Nursing, Faculty of Health Sciences, Japan University of Health Sciences, Saitama, Japan.
⁷ Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan; Department of Microbiology, Chiang Mai University, Thailand.
⁸ Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
⁹ Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan. Electronic address: ushijima-hiroshi@jcom.home.ne.jp.

Comment

Sheikh Ariful Hoque et al. Vaccine. 2018.

. 2018 Aug 16;36(34):5110-5111.

doi: 10.1016/j.vaccine.2018.05.004.

¹ Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan; Cell and Tissue Culture Laboratory, Centre for Advanced Research in Sciences (CARS), University of Dhaka, Dhaka, Bangladesh.
² Save the Children, Bangladesh.
³ Kobayashi Pediatric Clinic, Shizuoka, Japan.
⁴ Department of Developmental Medical Sciences, School of International Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
⁵ Infectious Diseases Department, International University of Health & Welfare (IUHW), Chiba, Japan.
⁶ Public Health Nursing, Faculty of Health Sciences, Japan University of Health Sciences, Saitama, Japan.
⁷ Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan; Department of Microbiology, Chiang Mai University, Thailand.
⁸ Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
⁹ Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan. Electronic address: ushijima-hiroshi@jcom.home.ne.jp.

No abstract available

Keywords: Rotavirus vaccine; Severity development; Test-negative design; Vaccine effectiveness.

Comment on

Role of rotavirus vaccination on an emerging G8P[8] rotavirus strain causing an outbreak in central Japan.
Hara M, Nakagomi O. Hara M, et al. Vaccine. 2018 Aug 16;36(34):5109. doi: 10.1016/j.vaccine.2018.05.002. Vaccine. 2018. PMID: 30103895 No abstract available.